0
18
INDIANAPOLIS: Eli Lilly and Co said on Monday (Aug 3) it started a late-stage trial testing whether one of its experimental COVID-19 antibody treatments can prevent the spread of infections in residents and staff at US nursing homes.
The Indianapolis-based drugmaker said it dosed the first participant in the placebo-controlled trial at a nursing home in Illinois.